Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 70518-3457

8 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-3457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Divalproex Structure)

Structure (Divalproex Structure)
Chemical structure diagram of divalproex sodium showing its molecular arrangement with sodium ions and multiple carbon chains.*
FDA Label Image

Figure1 (Divalproex Figure1)

Figure1 (Divalproex Figure1)
A chart comparing the percent reduction in CPS rate between divalproex sodium and placebo across a percentage of patients. The y-axis shows percentage reduction in CPS rate from -100% to 100%, indicating worsening to improvement, while the x-axis shows the percentage of patients from 100% to 0%. Two curves are plotted: a solid line for divalproex sodium and a dashed line for placebo.*
FDA Label Image

Figure2 (Divalproex Figure2)

Figure2 (Divalproex Figure2)
A cumulative distribution plot showing the percentage reduction in CPS rate against the percentage of patients for two groups: high dose (solid line) and low dose (dashed line). The vertical axis indicates improvement (positive values) and worsening (negative values), while the horizontal axis is the percentage of patients from 100 to 0.*
FDA Label Image

Mm1 (Divalproex Sodium 125mg 70518 3457 00)

Mm1 (Divalproex Sodium 125mg 70518 3457 00)
Divalproex Sodium 125 mg delayed-release capsule label showing quantity of 100 per box. The label indicates white/blue capsules with sprinkle pellets and includes the NDC 70518-3457-00. Manufactured by Ajanta Pharma USA Inc. and repackaged by RemedyRepack Inc., Indiana, PA. Storage and dosage instructions are partially visible.*
FDA Label Image

Mm2 (Divalproex Sodium 125mg 70518 3457 01)

Mm2 (Divalproex Sodium 125mg 70518 3457 01)
Label for Divalproex Sodium 125 mg delayed-release sprinkle capsules, quantity 1, labeled by RemedyRepack Inc. The label includes NDC 70518-3457-01, directions to see package insert, storage instructions, repackager information, and a QR code. Manufactured by Ajanta Pharma USA Inc., Bridgewater, NJ.*
FDA Label Image

Mm3 (Divalproex Sodium 125mg 70518 3457 02)

Mm3 (Divalproex Sodium 125mg 70518 3457 02)
Label for Divalproex Sodium delayed-release capsules, 125 mg strength, containing 100 capsules per box. The label indicates the product is repackaged by RemedyRepack Inc. It features storage instructions and manufacturer information for Ajanta Pharma USA Inc., Bridgewater, NJ.*
FDA Label Image

Mm4 (Divalproex Sodium 125mg 70518 3457 03)

Mm4 (Divalproex Sodium 125mg 70518 3457 03)
Label for Divalproex Sodium delayed-release capsule, 125 mg strength. The label states quantity as 1 capsule with coated pellets. It includes storage instructions and manufacturer information, showing it is repackaged by RemedyRepack Inc. in Indiana, PA, and manufactured by Ajanta Pharma USA Inc., Bridgewater, NJ.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Divalproex Sodium 125 mg delayed-release sprinkle capsules with 100 capsules per box. The label includes usage instructions to see the package insert, storage conditions between 20-25°C, and repackaging information by RemedyRepack Inc., Indiana, PA. The manufacturer listed is Ajanta Pharma USA Inc., Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.